
CD4see Platform
Translating precise in vivo Treg induction into targeted, long‑lasting therapies for autoimmune disease.
CD4see
CD4see is an injectable mRNA cocktail that locally reprograms CD4+ T cells into antigen‑specific regulatory T cells, restoring peripheral tolerance and aiming for durable, single‑dose control of autoimmune inflammation in IBD, psoriasis, and rheumatoid arthritis.


Indications
Immogen is advancing CD4see in IBD, psoriasis, and rheumatoid arthritis, with additional autoimmune indications in discovery. We collaborate with clinicians, academic centers, and industry partners on trial design, biomarker strategy, and indication‑specific CD4see mRNA cocktails.